Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2650 (LINC02650) is a long intergenic non-coding RNA (lincRNA) gene found in the human genome[1][3][5][7]. LINC02650 encodes a non-coding RNA transcript longer than 200 nucleotides and does not overlap any annotated protein-coding loci. LINC02650 belongs to a class of transcripts that may have roles in chromatin remodeling, transcriptional regulation, or modulation of gene expression, but its specific biological function, disease involvement, and potential as a therapeutic or biomarker target are currently unknown[9]. No interacting drugs, mechanisms of action, or disease associations are reported for this specific lincRNA, nor is it considered a conventional pharmacological target. LINC02650 is annotated in major genome databases with Entrez Gene ID 105378397 and HGNC ID HGNC:54135[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2650 (LINC02650).